Skip to main content

Day: November 1, 2024

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Second Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending January, February, and March 2025

GREENWICH, Conn., Nov. 01, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On October 24, 2024, our Board of Directors declared the following distributions on our common stock:Month Ending Record Date Payment Date Amount Per ShareJanuary 31, 2025 January 17, 2025 January 31, 2025 $0.09February 28, 2025 February 14, 2025 February 28, 2025 $0.09March 31, 2025 March 17, 2025 March 31, 2025 $0.09 Net asset value (“NAV”) per share as of September 30, 2024 stood at $4.76, compared with a NAV per share on June 30, 2024 of $4.91. Net investment income (“NII”), calculated...

Continue reading

Northway Financial, Inc. Announces Third Quarter Earnings

NORTH CONWAY, N.H., Nov. 01, 2024 (GLOBE NEWSWIRE) — Northway Financial, Inc. (the “Company”) (OTCQB: NWYF), the parent company of Northway Bank (the “Bank”), today reported net income for the quarter ended September 30, 2024 of $1.2 million, or $0.45 per basic common share, compared to $1.6 million, or $0.58 per basic common share for the quarter ended September 30, 2023. For the nine months ended September 30, 2024, the Company reported net income of $3.6 million, or $1.31 per basic common share, compared to $4.7 million, or $1.71 per basic common share for the same period in 2023. President and CEO William J. Woodward commented: “During the third quarter we continued to reduce our reliance on wholesale funding by putting a focus on retaining deposits and limiting our lending. Wholesale funding decreased by $122 million, significantly...

Continue reading

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced it will report its financial results from the third quarter ended September 30, 2024, before the financial markets open on Wednesday, November 6, 2024. The Company will host a live webcast the same morning at 8am ET, which can be accessed by visiting this registration link. This live webcast will also be available through the Events & Presentations page of the Investors + Media section of the company’s website www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following...

Continue reading

Ultralife Corporation Completes Acquisition of Electrochem Solutions, Inc.

NEWARK, N.Y., Nov. 01, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) for $50.0 million in cash from Integer Holdings Corporation (NYSE: ITGR) on October 31, 2024. “I am thrilled to welcome Electrochem to the growing Ultralife Team as another valued member that shares our core values, operating philosophy and strong commitment to both our associates and our long-standing customers. Having achieved our target of closing the acquisition of Electrochem by the end of October, we now look forward to working closely with Khristine Carroll, President – Electrochem, and her experienced team to jointly implement our integration playbook. Together, we will advance our strategy of more fully realizing the operating leverage of...

Continue reading

Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24% compared to the third quarter of 2023 Placed seven Growth Direct® systems in the third quarter of 2024, marking the highest number of system placements since the third quarter of 2021Included a multi-system order at an additional site of an existing top 20 global pharma customer as part of their global Growth Direct system rolloutAchieved inflection in gross margins to positive 8%, representing a significant company milestone and a 35 percentage point improvement compared to the third quarter of 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to the full year 2023LEXINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the...

Continue reading

Bombardier’s Must-Attend Safety Standdown Seminar Set to Open in Wichita, KS, Incites Aviation Professionals to Elevate their Influence

Under the theme “Elevate your Influence,” free-to-attend safety event provides life-long learning opportunities for a wide cross-section of industry influencers Dynamic event brings together more than 400 aviation professionals on site, hundreds more worldwide via webcast Jam-packed educational lineup includes must attend educational seminar sessions highlighting lessons of influence from the sports world, what we can from learn from National Transportation Safety Board (NTSB) near misses, aviation challenges and moreMONTRÉAL, Nov. 01, 2024 (GLOBE NEWSWIRE) — Bombardier today announced that its highly-influential Safety Standdown safety seminar has returned to Wichita, KS for another year of invaluable safety knowledge-based training. This dynamic three-day event, to be held on November 12-14 in person and online, features...

Continue reading

Stardust Power Announces Third Quarter 2024 Earnings Release Date, Conference Call

GREENWICH, Conn., Nov. 01, 2024 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium products, today announced that that it plans to release its third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Roshan Pujari, Founder and Chief Executive Officer and Uday Devasper, Chief Financial Officer will host a conference call at 5:30 pm ET on Wednesday, November 13, 2024 to discuss the Company’s performance. Participants may access the call by clicking the participant call link and ask questions: https://register.vevent.com/register/BI636e5a7167ac45fe86b733d151aba0af. Upon registering at the link, you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details. You...

Continue reading

AS Tallinna Vesi held an investor conference webinar to introduce the results of the third quarter of 2024

Today, on 1 November 2024, AS Tallinna Vesi held an investor conference webinar where Chairman of the Management Board, Chief Executive Officer Aleksandr Timofejev, and Member of the Management Board, Chief Financial Officer Taavi Gröön, introduced the performance of the 3rd quarter and 9 months of 2024. We thank all the participants! Webinar recording is available here and the presentation is available here. AS Tallinna Vesi´s financial and operational results for the 3rd quarter and 9 months of 2024 are available here.Additional information: Taavi GröönChief Financial OfficerAS Tallinna Vesi(+372) 626 2200taavi.groon@tvesi.ee

Continue reading

Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

MONACO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the third quarter (“Q3 2024”) and nine-months ended September 30, 2024. I. PROFITABILITY AND LIQUIDITYQ3 2024 Net Income available to common stockholders of $75.5 million ($0.63 per share). Q3 2024 Adjusted Net Income available to common stockholders1 of $80.7 million ($0.68 per share). Q3 2024 liquidity of $1,019.2 million2.II. SALE AND PURCHASE ACTIVITY Vessel AcquisitionsAgreement for:the acquisition of the 2011-built, 179,546 DWT capacity dry bulk vessel, Nord Magnes (tbr. Magnes). Expected conclusion of the acquisition within Q4 2024. the acquisition of the 2014-built, 61,090 DWT capacity dry bulk vessel, Alwine Oldendorff (tbr. Alwine). Expected conclusion of the acquisition...

Continue reading

Tulikivi Corporation interim report 1–9/2024: Strategic projects made good progress

TULIKIVI CORPORATION  INTERIM REPORT  1 NOV 2024 AT 1 PM – The Tulikivi Group’s net sales were EUR 7.2 million (EUR 9.1 million, 7–9/2023) in the third quarter and EUR 25.0 million (EUR 35.4 million, 1–9/2023) in the review period.– The Tulikivi Group’s operating profit was EUR 0.5 (1.3) million in the third quarter and EUR 1.6 (4.9) million in the review period.– The Tulikivi Group’s profit before taxes was EUR 0.3 million (1.1 million) in the third quarter and EUR 1.0 (4.4) million in the review period.– The equity ratio at the end of the review period was 50.9 per cent (47.5).– Order books stood at EUR 3.1 (11.5) million at the end of the review period.– The Suomussalmi talc project made good progress– Future outlook: Net sales in 2024 are expected to be EUR 33 to 37 million and the comparable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.